These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2562649)
1. Present status and future of monoclonal antibodies. Dillman RO Biotechnol Ther; 1989-1990; 1(2):87-107. PubMed ID: 2562649 [No Abstract] [Full Text] [Related]
2. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application? Oldham RK J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552 [No Abstract] [Full Text] [Related]
3. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy]. Renner C; Pfreundschuh M Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887 [No Abstract] [Full Text] [Related]
4. [Use of monoclonal antibodies in the immunotherapy of neoplasms]. Robak T Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121 [No Abstract] [Full Text] [Related]
5. Monoclonal antibodies and immunoconjugates for cancer treatment. Baldwin RW; Byers VS; Pimm MV Cancer Chemother Biol Response Modif; 1988; 10():397-415. PubMed ID: 3079393 [No Abstract] [Full Text] [Related]
6. Specific targeting of cancer with monoclonal antibodies: diagnostic and therapeutic applications. Abrams PG; Morgan AC; Fritzberg R Cancer Invest; 1990; 8(2):287-8. PubMed ID: 2400950 [No Abstract] [Full Text] [Related]
7. Monoclonal antibodies and immunoconjugates for cancer treatment. Baldwin RW; Byers VS Cancer Chemother Biol Response Modif; 1987; 9():409-31. PubMed ID: 3079412 [No Abstract] [Full Text] [Related]
8. Monoclonal antibodies for the treatment of cancer: therapeutic strategies. Houghton AN; Larson S Curr Opin Oncol; 1989 Dec; 1(2):258-65. PubMed ID: 2489969 [No Abstract] [Full Text] [Related]
9. The present and future role of monoclonal antibodies in the management of cancer. Front Radiat Ther Oncol; 1990; 24():1-269. PubMed ID: 2341046 [No Abstract] [Full Text] [Related]
10. Monoclonal antibodies for therapy of human malignant tumours. Bergh JC Eur J Surg Suppl; 1991 May; (561):59-64. PubMed ID: 1720051 [No Abstract] [Full Text] [Related]
11. Current therapies using monoclonal antibodies: II. Malignant disease. Distasio JA; Cheung NK Compr Ther; 1992 Apr; 18(4):40-4. PubMed ID: 1628483 [No Abstract] [Full Text] [Related]
12. XomaZyme-791 and XomaZyme-H65. Cancer Invest; 1989; 7(5):533. PubMed ID: 2620256 [No Abstract] [Full Text] [Related]
13. Monoclonal antibodies in immunodiagnosis and immunotherapy of human cancer. Colnaghi MI; Canevari S; Ménard S Eur J Surg Oncol; 1988 Feb; 14(1):1-7. PubMed ID: 3278936 [No Abstract] [Full Text] [Related]
14. [Monoclonal antibodies in the diagnosis and therapy of malignant tumors: current status amd future perspectives]. Obrist R Ther Umsch; 1988 Jun; 45(6):364-9. PubMed ID: 3413710 [No Abstract] [Full Text] [Related]
15. Antibodies come back from the brink. Holliger P; Hoogenboom H Nat Biotechnol; 1998 Nov; 16(11):1015-6. PubMed ID: 9831027 [No Abstract] [Full Text] [Related]
16. Monoclonal antibodies. Future potential in cancer chemotherapy. Kosmas C; Kalofonos H; Epenetos AA Drugs; 1989 Nov; 38(5):645-57. PubMed ID: 2689135 [No Abstract] [Full Text] [Related]
17. Perspectives of monoclonal antibodies in the acute leukaemias. Hervé P; Wijdenes J; Racadot E Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503 [No Abstract] [Full Text] [Related]
18. Medical applications of monoclonal antibodies. Clark MR Revis Biol Celular; 1986; 9():1-79. PubMed ID: 3324213 [TBL] [Abstract][Full Text] [Related]